amiodarone has been researched along with Genetic Predisposition in 6 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate the survival of patients with hypertrophic cardiomyopathy (HCM) after resuscitated ventricular fibrillation or syncopal sustained ventricular tachycardia (VT/VF) when treated with low dose amiodarone or implantable cardioverter defibrillators (ICDs)." | 3.70 | Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. ( Elliott, PM; McKenna, WJ; Poloniecki, J; Rowland, E; Sharma, S; Varnava, A, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, Y | 1 |
| Hayashi, T | 1 |
| Mitsuhashi, T | 1 |
| Sakakura, K | 1 |
| Yamada, Y | 1 |
| Wada, Y | 1 |
| Horie, M | 1 |
| Momomura, SI | 1 |
| Fujita, H | 1 |
| Montes, R | 1 |
| Nantes, O | 1 |
| Alonso, A | 1 |
| Zozaya, JM | 1 |
| Hermida, J | 1 |
| Kozák, M | 1 |
| Izákovicová Hollá, L | 1 |
| Krivan, L | 1 |
| Vasků, A | 1 |
| Sepsi, M | 1 |
| Semrád, B | 1 |
| Vácha, J | 1 |
| Lehtonen, A | 1 |
| Fodstad, H | 1 |
| Laitinen-Forsblom, P | 1 |
| Toivonen, L | 1 |
| Kontula, K | 1 |
| Swan, H | 1 |
| Wilson, BD | 1 |
| Lippmann, ML | 1 |
| Elliott, PM | 1 |
| Sharma, S | 1 |
| Varnava, A | 1 |
| Poloniecki, J | 1 |
| Rowland, E | 1 |
| McKenna, WJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic CardioMyopathy[NCT03259113] | 30 participants (Anticipated) | Interventional | 2017-08-16 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for amiodarone and Genetic Predisposition
| Article | Year |
|---|---|
Late presentation of arrhythmogenic right ventricular cardiomyopathy in an octogenarian associated with a pathogenic variant in the plakophilin 2 gene: a case report.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; C | 2019 |
The influence of polymorphisms of VKORC1 and CYP2C9 on major gastrointestinal bleeding risk in anticoagulated patients.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents | 2008 |
Endothelin-1 gene polymorphism in patients with malignant arrhythmias.
Topics: Aged; Amino Acid Sequence; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, | 2004 |
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; DNA Mutational Analysis; Electrocardiog | 2007 |
Susceptibility to amiodarone-induced pulmonary toxicity: relationship to the uptake of amiodarone by isolated lung cells.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Fibroblasts; Genetic Predisposition to | 1996 |
Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Child; Death, S | 1999 |